2 results
26/Feb/2025
DOI: 10.31744/einstein_journal/2025RW0753
ABSTRACT Introduction Traumatic brain injury is a leading cause of death and disability. Tranexamic acid, an antifibrinolytic agent, holds the potential for managing intracranial hemorrhages secondary to traumatic brain injury. However, its efficacy and safety remain subjects of ongoing debate. Objective To better clarify the efficacy and safety of tranexamic acid in that context and to evaluate the need for further studies. Methods We conducted a comprehensive search of seven electronic databases, eight study repositories, and tertiary sources between January […]
Keywords: Antifibrinolytic agents; Brain injuries, traumatic; Central nervous system; Craniocerebral trauma; Tranexamic acid
21/Nov/2024
DOI: 10.31744/einstein_journal/2024RW0734
ABSTRACT Objective: To study the efficacy of tranexamic acid at reducing bleeding during bipolar prostate resection surgery (B-TURP) in patients with benign prostatic hyperplasia. Methods: We searched registers with MESH terms “prostate hyperplasia,” “prostate surgery,” and “tranexamic acid.” Studies available in full and online, published from 2013 to 2023, in Portuguese, English, Spanish, and French were included; review articles were excluded. Information sources: Portal Regional da Biblioteca Virtual em Saúde and PubMed Central. The Cochrane RoB2 tool was used to […]
Keywords: Hemorrhage; Prostatic hyperplasia; Tranexamic acid; Transurethral resection of prostate